<SEC-DOCUMENT>0001493152-20-014995-index.html : 20200826
<SEC-HEADER>0001493152-20-014995.hdr.sgml : 20200826
<ACCEPTANCE-DATETIME>20200807184803
ACCESSION NUMBER:		0001493152-20-014995
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20200807
FILED AS OF DATE:		20200807
DATE AS OF CHANGE:		20200807
EFFECTIVENESS DATE:		20200810

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lineage Cell Therapeutics, Inc.
		CENTRAL INDEX KEY:			0000876343
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				943127919
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12830
		FILM NUMBER:		201085946

	BUSINESS ADDRESS:	
		STREET 1:		2173 SALK AVENUE
		STREET 2:		SUITE 200
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008
		BUSINESS PHONE:		5105213390

	MAIL ADDRESS:	
		STREET 1:		2173 SALK AVENUE
		STREET 2:		SUITE 200
		CITY:			CARLSBAD
		STATE:			CA
		ZIP:			92008

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIOTIME INC
		DATE OF NAME CHANGE:	19930328
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<TEXT>
Document 1 - file: formdef14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image_001.jpg
<TEXT>
Document 2 - file: image_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_002.jpg
<TEXT>
Document 3 - file: image_002.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>logo_001.jpg
<TEXT>
Document 4 - file: logo_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>proxy_001.jpg
<TEXT>
Document 5 - file: proxy_001.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>proxy_002.jpg
<TEXT>
Document 6 - file: proxy_002.jpg

</DOCUMENT>
</SEC-DOCUMENT>